Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2014 08:51 ET | Source: Novavax, Inc.

ICAAC Presentation: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus in a Comparable Manner to Infants Prophylaxed With Palivizumab

Immunization of pregnant baboons generates anti-F IgG antibodies that are transferred from mothers to their infants When challenged with RSV, infant baboons born to immunized mothers show...
September 06, 2014 10:49 ET | Source: Novavax, Inc.

Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC

GAITHERSBURG, Md., Sept. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
September 03, 2014 18:13 ET | Source: Novavax, Inc.

CORRECTING and REPLACING -- Novavax to Present RSV Vaccine Preclinical Results at ICAAC

GAITHERSBURG, Md., Sept. 3, 2014 (GLOBE NEWSWIRE) -- In a release issued earlier today by Novavax, Inc.(Nasdaq:NVAX), the headline read "Novavax to Present RSV Vaccine Clinical and Preclinical...
September 03, 2014 16:40 ET | Source: Novavax, Inc.

Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC

GAITHERSBURG, Md., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
August 07, 2014 15:47 ET | Source: Novavax, Inc.

Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference

GAITHERSBURG, Md., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
August 06, 2014 16:19 ET | Source: Novavax, Inc.

Novavax Reports Second-Quarter 2014 Financial Results

GAITHERSBURG, Md., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
July 30, 2014 16:10 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014

ROCKVILLE, Md., July 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
June 23, 2014 16:11 ET | Source: Novavax, Inc.

Novavax Recognized as One of The Washington Post's Top Workplaces

GAITHERSBURG, Md., June 23, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
June 19, 2014 16:10 ET | Source: Novavax, Inc.

Novavax Announces Management Promotions

GAITHERSBURG, Md., June 19, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of recombinant...
June 18, 2014 16:40 ET | Source: Novavax, Inc.

Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus

GAITHERSBURG, Md., June 18, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...